Stock Scorecard

Stock Summary for Novo Nordisk (NVO) - $65.40 as of 5/13/2025 8:54:29 PM EST

Total Score

16 out of 30

Safety Score

65 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for NVO

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for NVO

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for NVO

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for NVO

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for NVO (65 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 8
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 4
Operating Margin (Max of 10) 8
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 8
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for NVO

Why Weight-Loss Developer Stocks Tumbled on Tuesday 5/13/2025 11:08:00 PM
Is the Fed on the Right Track? 5/13/2025 4:22:00 PM
2 Monster Stocks in the Making to Buy Now and Hold for 10 Years 5/13/2025 1:45:00 PM
The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen 5/13/2025 1:22:00 PM
Arc tries fresh solution to youth mental health crisis 5/13/2025 4:00:00 AM
Pharma Stocks Hit by Trump's Vow to Cut US Prescription Drug Costs 5/12/2025 1:37:00 PM
Novo Nordisk's Sogroya Supports Effective Weekly Alternative To Daily Hormone Therapy Across Three Growth Disorders - Novo Nordisk ( NYSE:NVO ) 5/12/2025 1:24:00 PM
Culture, jazz and decision-making: The Economist's "Boss Class" podcast on management returns with season two 5/12/2025 1:00:00 PM
Mark Cuban Challenges Charlie Kirk's Take On Big Pharma, Highlights Role Of PBMs In Drug Price Surge: 'For Your Company…Ask Your PBM For A List Of Claims' - Johnson & Johnson ( NYSE:JNJ ) , Eli Lilly ( NYSE:LLY ) 5/12/2025 11:40:00 AM
Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket - Amgen ( NASDAQ:AMGN ) , Bristol-Myers Squibb ( NYSE:BMY ) 5/12/2025 8:32:00 AM

Financial Details for NVO

Company Overview
Ticker NVO
Company Name Novo Nordisk
Country USA
Description Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 3/31/2025
Next Earnings Date N/A

Stock Price History
Last Day Price 65.40
Price 4 Years Ago 53.04
Last Day Price Updated 5/13/2025 8:54:29 PM EST
Last Day Volume 10,235,328
Average Daily Volume 11,103,617
52-Week High 145.26
52-Week Low 57.00
Last Price to 52 Week Low 14.74%

Valuation Measures
Trailing PE 19.19
Industry PE 29.04
Sector PE 49.22
5-Year Average PE 25.41
Free Cash Flow Ratio 5.66
Industry Free Cash Flow Ratio 19.04
Sector Free Cash Flow Ratio 31.82
Current Ratio Most Recent Quarter 0.74
Total Cash Per Share 11.56
Book Value Per Share Most Recent Quarter 31.21
Price to Book Ratio 14.44
Industry Price to Book Ratio 38.21
Sector Price to Book Ratio 30.58
Price to Sales Ratio Twelve Trailing Months 0.97
Industry Price to Sales Ratio Twelve Trailing Months 93.50
Sector Price to Sales Ratio Twelve Trailing Months 25.54
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics
Total Shares Outstanding 3,368,500,000
Market Capitalization 220,299,900,000
Institutional Ownership N/A

Dividends
Ex-Dividend Date 3/31/2025
Previous Dividend Amount 0.5169
Current Dividend Amount 1.0992
Total Years Dividend Increasing 5
Trailing Annual Dividend Rate 1.62
Trailing Annual Dividend Yield 2.39%
Forward Annual Dividend Rate 2.20
Forward Annual Dividend Yield 3.25%
5-Year Dividend Payments Count 10
3-Year Average Dividend Yield 1.71%
5-Year Average Dividend Yield 1.34%
1-Year Dividend Growth Rate Percentage 51.96%
3-Year Dividend Growth Rate Percentage 23.27%
5-Year Dividend Growth Rate Percentage 31.46%
All-Time Dividend Growth Rate Percentage 9.39%
Dividend Payout Ratio 47.12%

Income Statement
Quarterly Earnings Growth YOY 15.00%
Annual Earnings Growth 20.68%
Reported EPS 12 Trailing Months 3.53
Reported EPS Past Year 6.53
Reported EPS Prior Year 8.73
Net Income Twelve Trailing Months 104,615,000,000
Net Income Past Year 100,988,000,000
Net Income Prior Year 83,683,000,000
Quarterly Revenue Growth YOY 19.50%
5-Year Revenue Growth 18.94%
Operating Margin Twelve Trailing Months 49.70%

Balance Sheet
Total Cash Most Recent Quarter 38,938,000,000
Total Cash Past Year 15,655,000,000
Total Cash Prior Year 14,392,000,000
Net Cash Position Most Recent Quarter -57,372,000,000
Net Cash Position Past Year -68,591,000,000
Long Term Debt Past Year 84,246,000,000
Long Term Debt Prior Year 15,976,000,000
Total Debt Most Recent Quarter 96,310,000,000
Equity to Debt Ratio Past Year 0.63
Equity to Debt Ratio Most Recent Quarter 0.59
Total Stockholder Equity Past Year 143,486,000,000
Total Stockholder Equity Prior Year 106,561,000,000
Total Stockholder Equity Most Recent Quarter 138,540,000,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months 74,744,000,000
Free Cash Flow Per Share Twelve Trailing Months 22.19
Free Cash Flow Past Year 69,659,000,000
Free Cash Flow Prior Year 70,012,000,000

Options
Put/Call Ratio 0.97
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -0.39
MACD Signal -1.50
20-Day Bollinger Lower Band 56.62
20-Day Bollinger Middle Band 76.46
20-Day Bollinger Upper Band 96.31
Beta 0.21
RSI 47.92
50-Day SMA 105.19
150-Day SMA 89.82
200-Day SMA 79.76

System
Modified 5/13/2025 6:47:38 AM EST